Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-29T18:27:54.336Z Has data issue: false hasContentIssue false
  • English
  • Français

State Laws Regulating Prescribing of Controlled Substances: Balancing the Public Health Problems of Chronic Pain and Prescription Painkiller Abuse and Overdose

Published online by Cambridge University Press:  01 January 2021

Andrea M. Garcia
Get access Rights & Permissions [Opens in a new window]

Extract

According to the Institute of Medicine, chronic pain affects at least 116 million adults in the United States (U.S.), which is more than the total affected by heart disease, cancer, and diabetes combined. Pain costs the nation up to $635 billion each year in medical treatment and lost productivity. It has been conceptualized as a public health problem due to its prevalence, seriousness, disparities, vulnerable populations, the utility of population health strategies, and the importance of prevention at both the population and individual levels. For many patients, treatment of pain is inadequate due to uncertain diagnoses, societal stigma, the lack of effective treatments, and inadequate patient and clinician knowledge about the best ways to manage pain. This article explores the inadequate treatment of pain in the U.S. and the subsequent rise of prescription painkiller abuse, misuse, and overdoses. This is followed by a review of the actions taken by states to regulate the prescribing of controlled substances.

Type
Supplement
Information
Journal of Law, Medicine & Ethics , Volume 41 , Issue S1 , Spring 2013 , pp. 42 - 45
Copyright
Copyright © American Society of Law, Medicine and Ethics 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Resources

Institute of Medicine, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research (June 2011), available at <http://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx> (last visited January 8, 2013).+(last+visited+January+8,+2013).>Google Scholar
Berry, P. H. and Dabl, J. L. “The New JCAHO Pain Standards: Implications for Pain Management Nurses,” Pain Management Nursing 1, no. 1(2000): 3–12, at 5.CrossRefGoogle Scholar
Board of Medical Examiners, State of Oregon, In the Matter of Paul Andre Builder, MD, Stipulated Orders, available at <http://www.drugpolicy.org/docUploads/Bilder_v_Oregon_Stipulated_Order.pdf> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
“Oregon Board Disciplines Doctor for Not Treating Patients’ Pain,” New York Times, September 4, 1999, available at <http://www.nytimes.com/1999/09/04/us/oregon-board-disciplines-doctor-for-not-treating-patients-pain.html> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Department of Veteran's Affairs, Pain as the Fifth Vital Sign Toolkit (October 2000), available at <http://www.va.gov/PAINMANAGEMENT/docs/TOOLKIT.pdf> (last visited January 9, 2013). (last visited January 9, 2013).' href=https://scholar.google.com/scholar?q=Department+of+Veteran's+Affairs,+Pain+as+the+Fifth+Vital+Sign+Toolkit+(October+2000),+available+at++(last+visited+January+9,+2013).>Google Scholar
The Joint Commission, “Facts about Pain Management,” available at, <http://www.jointcommission.org/assets/1/18/pain_management.pdf> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Furrow, B. R. “Pain Management and Provider Liability: No More Excuses” Journal of Law, Medicine & Ethics 29, no. 1(2001): 28–51.CrossRefGoogle Scholar
Bergman v. Eden Medical Center, No. H205732-1 (Cal. Super. Ct., Alameda County, 2001).Google Scholar
Federation of State Medical Boards, “Model Policy for the Use of Controlled Substances for the Treatment of Pain,” available at <http://www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Lembke, A. “Why Doctors Prescribe Opioids to Known Opioid Abusers” New England Journal of Medicine 367, no. 17(2012): 1580–1581.CrossRefGoogle Scholar
Centers for Disease Control and Prevention, Vital Signs, “Prescription Painkiller Overdoses in the US,” (November 2011), available at <http://www.cdc.gov/vitalsigns/PainkillerOverdoses/> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Id.Google Scholar
Id.Google Scholar
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2009: National Estimates of Drug-Related Emergency Department Visits, HHS Publication No. (SMA) 11-4659, DAWN Series D-35; Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011; Patrick, S. W. et al., “Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000–2009,” JAMA 307, no. 18(2012): 1934–1940.CrossRefGoogle Scholar
New York, Assembly Bill 10623 (2012).Google Scholar
Tennessee, Senate Bill 2235 (2012).Google Scholar
Baker, A. and Lane, J. “Pill Mills: What Are They and Why Be Concerned?” Georgia Composite Medical Board, available at <http://associationdatabase.com/aws/NADDI/asset_manager/get_file/27388/2010-ga-news-article.pdf> (last visited January 9, 2013).Google Scholar
CDC, “Laws: Regulating Pain Clinics,” available at <http://www.cdc.gov/homeandrecreationalsafety/Poisoning/laws/pain_clinic.html> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Washington State Department of Health, Pain Management, “Adopted Rules,” available at <http://www.doh.wa.gov/PublicHealthandHealthcareProviders/HealthcareProfessionsandFacilities/PainManagement/AdoptedRules.aspx> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Wash. Admin. Code § 246-919-826, “Consultation – Exemptions for the Physician,” available at <http://www.doh.wa.gov/Portals/1/Documents/3000/MDPAPainMgmt.pdf> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Reifler, L. M. et al., “Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse” Pain Medicine 13, no. 3(2012): 434–442.CrossRefGoogle Scholar
Worley, J. “Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research” Issues in Mental Health Nursing 33, no. 5(2012): 319–328.CrossRefGoogle Scholar
United States, Drug Enforcement Administration, “Florida Law Enforcement Prescription Drug Efforts Produce Positive Results Purchases of Oxycodone Decline,” available at <http://www.justice.gov/dea/pubs/states/newsrel/2012/mia013012.html> (last visited November 2, 2012).+(last+visited+November+2,+2012).>Google Scholar
“Pill Mill Fight Spans River,” The Columbus Dispatch, April 20, 2011, available at <http://www.dispatch.com/content/stories/local/2011/04/20/pill-mill-fight-spans-river.html> (last visited January 9, 2013).+(last+visited+January+9,+2013).>Google Scholar
Bronson-Potts, H. “Prosecution of Doctor in Overdose Cases Worries Physicians” Los Angeles Times, September 11, 2012, available at <http://articles.latimes.com/2012/sep/11/local/la-me-doctor-prescriptions-20120912> (last visited January 9, 2013).Google Scholar